Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?

Author(s): Chris T. Derk.

Journal Name: Recent Patents on Inflammation & Allergy Drug Discovery

Volume 1 , Issue 2 , 2007

Become EABM
Become Reviewer

Abstract:

One of the growth factors that appear to play a crucial role in the pathogenesis of systemic sclerosis is TGF-β. The three functionally and structurally similar human isoforms of TGF-β play important roles in embryonic development, in the regulation of tissue repair following injury and in immune responses. Systemic sclerosis fibroblasts express increased levels of TGF-β receptors on their surface which in turn results in increased signalimg of TGF-β induced collagen gene expression. Some of the patents and intricate pathways that mediate the stimulation of collagen gene expression by TGF-β have recently been described and a potential inhibition of these pathways may lead to novel therapeutic targets for systemic sclerosis.

Keywords: Systemic sclerosis, scleroderma, fibrosis, transforming growth factor-beta

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 1
ISSUE: 2
Year: 2007
Page: [142 - 145]
Pages: 4
DOI: 10.2174/187221307780979883
Price: $58

Article Metrics

PDF: 3